TrumpRx lists many medicines at prices higher than paid in UK

Reuters found that TrumpRx.gov does not consistently offer lower prescription drug prices than those paid in the United Kingdom, contradicting the administration's pledge to make U.S. drugs the cheapest globally. The discrepancy undercuts political messaging on drug-cost reform and is unlikely to drive material moves in healthcare equities in the near term.

Analysis

Reuters found that TrumpRx.gov does not consistently offer lower prescription drug prices than those paid in the United Kingdom, contradicting the administration's pledge to make U.S. drugs the cheapest globally. The discrepancy undercuts political messaging on drug-cost reform and is unlikely to drive material moves in healthcare equities in the near term.